Join the club for FREE to access the whole archive and other member benefits.

J. Craig Venter

Founder, Chairman and CEO at J. Craig Venter Institute and Author

J. Craig Venter, PhD, is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. Dr. Venter is Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), a not-for-profit, research organization with approximately 200 scientists and staff dedicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics.

Dr. Venter also is a co-founder of Synthetic Genomics, Inc. (SGI) and Human Longevity, Inc. (HLI). SGI is a privately held company developing products and solutions including sustainable bio-fuels, vaccines, biotherapeutics and transplantable organs. HLI is a genomic-based, health intelligence company empowering proactive healthcare.

Visit website: https://www.jcvi.org/about/jcventer

 JCVenter

See also: Institute J. Craig Venter Institute (JCVI) - Non-profit genomics research institute.

Details last updated 23-Jan-2020

J. Craig Venter Blog Posts

Perfect storm for gene therapy?
30-Jan-2014

Perfect storm for gene therapy?

Genome editing combined with stem cell generation could produce life extending therapies when boosted with big data

J. Craig Venter Creations

Life at the Speed of Light: From the Double Helix to the Dawn of Digital Life

Amazon

Book about synthetic genomics written by J. Craig Venter

J. Craig Venter News

Human longevity company secures $39.8M to advance AI-driven breakthroughs

Human longevity company secures $39.8M to advance AI-driven breakthroughs

Longevity Technology - 22-Aug-2024

Extending healthspan and lifespan through personalized, preventive care

Pre-mature deaths in adults may be prevented, shown by HLI's largest study

Pre-mature deaths in adults may be prevented, shown by HLI's largest study

EurekAlert! - 27-Jan-2020

Made possible by early detection of disease and disease risks through whole genome sequencing

Clinicians identified adults at risk for key health conditions

Clinicians identified adults at risk for key health conditions

Business Wire - 27-Jan-2020

Studies were done by integrating whole-genome sequencing with advanced imaging and blood metabolites

Craig Venter talks through his new Health Nucleus clinic

Craig Venter talks through his new Health Nucleus clinic

Aging Reversed - 13-Jan-2017

The new approach to healthcare: proactive preventative personalised predictive Life threaten...

If death becomes optional, will only the rich get to live forever?

If death becomes optional, will only the rich get to live forever?

Fusion - 03-Mar-2016

They will not be old in mind or body, only in years. Likely to amplify economic inequality. Tho...

Harvard professor believes anti-aging pill is only a few years away

Harvard professor believes anti-aging pill is only a few years away

Sydney Morning Herald - 03-Oct-2015

If the greatest driver of disease in old age is old age itself, then why not find a cure for agei...

Human Longevity Inc aiming for 1 million genome study

Human Longevity Inc aiming for 1 million genome study

Next Big Future - 16-Jun-2015

HLI (Human Longevity Inc) has purchased two Illumina HiSeq X Ten Sequencing Systems to study inte...

The rich get older

The rich get older

Cosmos - 01-Jun-2015

Gains in US life expectancy mostly benefiting those with higher income. Income is the single big...

Everyday drugs could give extra years of life

Everyday drugs could give extra years of life

New Scientist - 01-Oct-2014

Rapamycin in mice The study was published in the Diabetes, Obesity and Metabolism journal.